DNACommon stockNYSE
DNA Common stock
This is the ticker-level security page. The issuer is Ginkgo Bioworks Holdings, Inc..
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$180.6M
Net income TTM
-$339.5M
Total assets
$1.2B
Total debt
Not available
Total equity
$559.8M
Profit margin
Not available
ROE
Not available
ROA
-28.6%
Latest issuer financial snapshot: 2024-12-31